ARSJ (Gene)

Synonyms:ARSJ, ASJ, ENTREZ:79642, HGNC:26286, MIM:610010, NM_001354210, NM_001354211, NM_024590, NP_001341139, NP_001341140, NP_078866, XM_011532238, XM_011532239, XM_017008592, XM_017008593, XM_017008594, XM_017008595, XM_017008597, XM_017008598, XM_017008599, XM_017008600, XM_024454214, XM_024454215, XM_024454216, XP_011530540, XP_011530541, XP_016864081, XP_016864082, XP_016864083, XP_016864084, XP_016864086, XP_016864087, XP_016864088, XP_016864089, XP_024309982, XP_024309983, XP_024309984, arylsulfatase family member J
Omim:OMIM:610010
Id:448636c7-4bbc-5344-a808-1a4726467291
Hgnc:HGNC:26286
Entrez:79642
Description:arylsulfatase family member J
Sulfatases (EC 3.1.5.6), such as ARSJ, hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules (Sardiello et al., 2005 [PubMed 16174644]).[supplied by OMIM, Mar 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ARSJ's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ARSJ.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ARSJ.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ARSJ.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ARSJ.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.